概括
婴儿和儿童可以耐受较高的血清数位毒素水平比成年人没有毒性. 这表明调整剂量可能是必要的,以有效的儿科数字治疗和毒性管理.
科学领域:
- 药理学 药理学是指药理学的学科.
- 儿科 儿科 儿科
- 心脏病学 心脏病学
背景情况:
- 像Digitoxin这样的Digitalis糖化物对于治疗儿科心力衰竭和心律失常至关重要.
- 了解数字毒素的特定年龄治疗范围对于安全有效的治疗至关重要.
研究的目的:
- 为了比较接受维持治疗的婴儿和儿童的血清数字毒素水平与成年人的水平.
- 评估血清数位毒素度与儿科群体临床毒性之间的关系.
主要方法:
- 在18名婴儿和23名接受维持治疗的儿童中测量了血清数字毒素水平.
- 记录了剂量,数字化指示和毒性迹象.
- 儿科水平与成熟的成人水平进行了比较.
主要成果:
- 婴儿 (30 ng/ml) 和儿童 (34 ng/ml) 的平均血清数字毒素水平没有显著差异.
- 儿童水平明显高于成人水平 (24 ng/ml).
- 显示有毒性的患者有显著更高的血清数位毒素水平 (71-72 ng/ml).
结论:
- 婴儿和儿童似乎比成年人更能耐受较高的血清数字毒素度.
- 儿科患者可能需要更高的mg/kg剂量来获得治疗效果.
- 血清数字毒素监测对于优化数字化和儿童毒性管理至关重要.
相关概念视频
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Diphtheria
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...


